Samuel H. Speck

12.6k total citations · 2 hit papers
169 papers, 10.7k citations indexed

About

Samuel H. Speck is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Samuel H. Speck has authored 169 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Oncology, 105 papers in Epidemiology and 33 papers in Immunology. Recurrent topics in Samuel H. Speck's work include Viral-associated cancers and disorders (133 papers), Cytomegalovirus and herpesvirus research (102 papers) and Herpesvirus Infections and Treatments (63 papers). Samuel H. Speck is often cited by papers focused on Viral-associated cancers and disorders (133 papers), Cytomegalovirus and herpesvirus research (102 papers) and Herpesvirus Infections and Treatments (63 papers). Samuel H. Speck collaborates with scholars based in United States, United Kingdom and Germany. Samuel H. Speck's co-authors include Herbert W. Virgin, Erik K. Flemington, Karen E. Weck, Jack L. Strominger, M Woisetschlaeger, Albert J. Dal Canto, Brian C. Schaefer, Christopher M. Collins, Linda F. van Dyk and Don Ganem and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Samuel H. Speck

169 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete sequence and genomic analysis of murine gammaherpesvirus 68

1997 647 citations Herbert W. Virgin, Samuel H. Speck et al. profile →
E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

1993 286 citations Samuel H. Speck et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Samuel H. Speck

Since Specialization

Citations

This map shows the geographic impact of Samuel H. Speck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel H. Speck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel H. Speck more than expected).

Fields of papers citing papers by Samuel H. Speck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel H. Speck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel H. Speck. The network helps show where Samuel H. Speck may publish in the future.

Co-authorship network of co-authors of Samuel H. Speck

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel H. Speck. A scholar is included among the top collaborators of Samuel H. Speck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel H. Speck. Samuel H. Speck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Type I Interferon Signaling Controls Gammaherpesvirus Latency In Vivo 2022 ·Pathogens ·Johannes Schwerk, (unknown), Kendra A. Bussey, Stefan Lienenklaus, Siegfried Weiß, Luka Čičin‐Šain, Andrea Kröger, Ulrich Kalinke, Christopher M. Collins, Samuel H. Speck, Martin Messerle, Dagmar Wirth, Melanie M. Brinkmann, H. Häuser, Mario Köster	6
2	Interleukin 16 contributes to gammaherpesvirus pathogenesis by inhibiting viral reactivation 2020 ·PLoS Pathogens ·Shuai Liu, (unknown), Jie Li, (unknown), Ran Jia, Zhongshun Liu, (unknown), Ying Gao, Mu Liu, (unknown), Zhikang Qian, Dongming Zhou, Samuel H. Speck, Xiaozhen Liang	8
3	CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice 2015 ·PLoS ONE ·(unknown), (unknown), Brian S. Wakeman, (unknown), Carol A. Wilke, Cynthia L. Courtney, Bethany B. Moore, Samuel H. Speck	12
4	Rapamycin ameliorates the CTLA4-Ig–mediated defect in CD8+ T Cell Immunity During Gammaherpesvirus Infection 2015 ·American Journal of Transplantation ·David F. Pinelli, Brian S. Wakeman, Maylene E. Wagener, Samuel H. Speck, Mandy L. Ford	14
5	RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition 2014 ·Proceedings of the National Academy of Sciences ·William J. Kaiser, Lisa P. Daley‐Bauer, Roshan J. Thapa, Pratyusha Mandal, Scott B. Berger, Chunzi Huang, Aarthi Sundararajan, Hongyan Guo, Linda Roback, Samuel H. Speck, John Bertin, Peter J. Gough, Siddharth Balachandran, Edward S. Mocarski	233
6	Murine Gammaherpesvirus M2 Protein Induction of IRF4 via the NFAT Pathway Leads to IL-10 Expression in B Cells 2014 ·PLoS Pathogens ·Udaya S. Rangaswamy, Samuel H. Speck	42
7	Expansion of Murine Gammaherpesvirus Latently Infected B Cells Requires T Follicular Help 2014 ·PLoS Pathogens ·Christopher M. Collins, Samuel H. Speck	41
8	Heterologous Immunity Triggered by a Single, Latent Virus in Mus musculus: Combined Costimulation- and Adhesion- Blockade Decrease Rejection 2013 ·PLoS ONE ·(unknown), (unknown), (unknown), Danxia Duan, Linda Stempora, (unknown), Jennifer A. Cheeseman, Kelly Hamby, Samuel H. Speck, Christian P. Larsen, Allan D. Kirk, Leslie S. Kean	14
9	Inhibition of NF-κB Signaling Reduces Virus Load and Gammaherpesvirus-Induced Pulmonary Fibrosis 2010 ·American Journal Of Pathology ·Laurie T. Krug, Edilson Torres-González, Qianhong Qin, Dan C. Sorescu, Mauricio Rojas, Arlene A. Stecenko, Samuel H. Speck, Ana L. Mora	28
10	Expansion of Effector Memory TCR Vβ4+CD8+ T Cells Is Associated with Latent Infection-Mediated Resistance to Transplantation Tolerance 2008 ·The Journal of Immunology ·(unknown), (unknown), (unknown), Andrew G. Evans, Leslie S. Kean, Samuel H. Speck, Christian P. Larsen, Shivaprakash Gangappa	26
11	Control of Virus Reactivation Arrests Pulmonary Herpesvirus-induced Fibrosis in IFN-γ Receptor–deficient Mice 2007 ·American Journal of Respiratory and Critical Care Medicine ·Ana L. Mora, Edilson Torres-González, Mauricio Rojas, Jianguo Xu, Jeffrey D. Ritzenthaler, Samuel H. Speck, Jesse Roman, Kenneth L. Brigham, Arlene A. Stecenko	69
12	Identification of an Rta responsive promoter involved in driving γHV68 v-cyclin expression during virus replication 2007 ·Virology ·Robert D. Allen, (unknown), Samuel H. Speck	11
13	Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice 2005 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Ana L. Mora, Charles R. Woods, Anapatricia García, Jianguo Xu, Mauricio Rojas, Samuel H. Speck, Jesse Roman, Kenneth L. Brigham, Arlene A. Stecenko	85
14	Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks 2005 ·Virology ·Jason W. Upton, Linda F. van Dyk, Samuel H. Speck	29
15	Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta 2003 ·Virology ·(unknown), Samuel H. Speck	52
16	Critical role for a high-affinity chemokine-binding protein in γ-herpesvirus–induced lethal meningitis 2002 ·Journal of Clinical Investigation ·Victor van Berkel, Beth Levine, Sharookh B. Kapadia, James E. Goldman, Samuel H. Speck, Herbert W. Virgin	73
17	Structural Basis of Chemokine Sequestration by a Herpesvirus Decoy Receptor 2002 ·Cell ·Jennifer M. Alexander, Christopher A. Nelson, Victor van Berkel, Elaine K. Lau, Joey Studts, Tom J. Brett, Samuel H. Speck, Tracy M. Handel, Herbert W. Virgin, Daved H. Fremont	92
18	Constitutive Activation of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Gene Transcription by IRF1 and IRF2 during Restricted EBV Latency 1997 ·Molecular and Cellular Biology ·Brian C. Schaefer, (unknown), Jack L. Strominger, Samuel H. Speck	62
19	Binding of the Ubiquitous Cellular Transcription Factors Sp1 and Sp3 to the ZI Domains in the Epstein–Barr Virus Lytic Switch BZLF1 Gene Promoter 1997 ·Virology ·Shaofan Liu, Ana M. Borras, (unknown), Guntram Suske, Samuel H. Speck	53
20	Cyclosporin A and FK506 Block Induction of the Epstein-Barr Virus Lyric Cycle by Anti-Immunoglobulin 1995 ·Virology ·Anne E. Goldfeld, (unknown), Shaofan Liu, Erik K. Flemington, Jack L. Strominger, Samuel H. Speck	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact